J

Thorac Oncol 2009, 4:891–910.PubMedCrossRef 52. Xie Y, Minna JD: Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy. J Clin Oncol 28:4404–4407. 53. Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P: The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol 2008, Sapitinib purchase 3:457–466.PubMedCrossRef 54. Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, et al.: A novel clinical prognostic score incorporating FHPI molecular weight the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer 2009, 66:365–371.PubMedCrossRef 55. Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP: Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Cancer 56. Jonnalagadda S, Smith C, Mhango G, Wisnivesky JP: The Number of Lymph Node Metastases as a Prognostic Factor in Patients With N1 Non-small Cell Lung Cancer. Chest 140:433–440. 57. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, et al.: A Akt inhibitor five-gene signature

and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007, 356:11–20.PubMedCrossRef 58. Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, et al.: A five-gene and corresponding protein signature for stage-I lung adenocarcinoma Adenosine prognosis. Clin Cancer Res 17:1490–1501. 59. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S: Evaluation of microRNA expression profiles that may predict recurrence

of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70:36–45. 60. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, et al.: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006, 355:570–580.PubMedCrossRef 61. Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M, et al.: Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res 2008, 14:4794–4799.PubMedCrossRef 62. Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T: A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst 2007, 99:858–867.PubMedCrossRef 63. Konopa K: Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer? Ann Oncol 21(Suppl 7):vii199–202. 64.